NO307170B1 - Farmasoetisk avgivelsessystem og fremgangsmåte for fremstilling derav - Google Patents

Farmasoetisk avgivelsessystem og fremgangsmåte for fremstilling derav

Info

Publication number
NO307170B1
NO307170B1 NO930743A NO930743A NO307170B1 NO 307170 B1 NO307170 B1 NO 307170B1 NO 930743 A NO930743 A NO 930743A NO 930743 A NO930743 A NO 930743A NO 307170 B1 NO307170 B1 NO 307170B1
Authority
NO
Norway
Prior art keywords
release
minocycline
systems
preparation
medium
Prior art date
Application number
NO930743A
Other languages
English (en)
Norwegian (no)
Other versions
NO930743L (no
NO930743D0 (no
Inventor
Nitin Vadilal Sheth
Jr Joseph James Valorose
Keith Anthony Ellway
Madurai Gurusamy Ganesan
Keiran George Mooney
Jerry Bain Johnson
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO930743D0 publication Critical patent/NO930743D0/no
Publication of NO930743L publication Critical patent/NO930743L/no
Publication of NO307170B1 publication Critical patent/NO307170B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Magnetic Treatment Devices (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Laser Surgery Devices (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Position Fixing By Use Of Radio Waves (AREA)
NO930743A 1992-03-02 1993-03-01 Farmasoetisk avgivelsessystem og fremgangsmåte for fremstilling derav NO307170B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/844,109 US5262173A (en) 1992-03-02 1992-03-02 Pulsatile once-a-day delivery systems for minocycline

Publications (3)

Publication Number Publication Date
NO930743D0 NO930743D0 (no) 1993-03-01
NO930743L NO930743L (no) 1993-09-03
NO307170B1 true NO307170B1 (no) 2000-02-21

Family

ID=25291839

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930743A NO307170B1 (no) 1992-03-02 1993-03-01 Farmasoetisk avgivelsessystem og fremgangsmåte for fremstilling derav

Country Status (24)

Country Link
US (2) US5262173A (cs)
EP (1) EP0558913B1 (cs)
JP (1) JPH069407A (cs)
KR (1) KR100270491B1 (cs)
CN (1) CN1039194C (cs)
AT (1) ATE181504T1 (cs)
AU (1) AU656841B2 (cs)
CA (1) CA2090561C (cs)
CZ (1) CZ283684B6 (cs)
DE (1) DE69325402T2 (cs)
DK (1) DK0558913T3 (cs)
ES (1) ES2134221T3 (cs)
FI (1) FI110163B (cs)
GR (1) GR3031028T3 (cs)
HU (1) HU219580B (cs)
IL (1) IL104865A (cs)
LV (1) LV12399B (cs)
MX (1) MX9300998A (cs)
NO (1) NO307170B1 (cs)
NZ (1) NZ245951A (cs)
PL (1) PL171609B1 (cs)
SG (1) SG47785A1 (cs)
TW (1) TW299235B (cs)
ZA (1) ZA931444B (cs)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
EP0804174A4 (en) * 1993-07-21 1998-09-09 Univ Kentucky Res Found MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9518465D0 (en) * 1995-09-09 1995-11-08 Smithkline Beecham Seiyaku Kk Pharmaceuticals
ZA974359B (en) * 1996-05-23 1998-05-12 Zeneca Ltd Microencapsulated compositions.
US5932437A (en) * 1998-04-13 1999-08-03 Genesis Laboratories, Inc. Control of lyme disease spirochete
WO2000019985A2 (en) * 1998-10-01 2000-04-13 Novartis Ag New sustained release oral formulations
JP2000119181A (ja) * 1998-10-06 2000-04-25 Kureha Chem Ind Co Ltd エスクレチン及びその誘導体の放出制御経口製剤
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
RU2236847C2 (ru) * 1998-11-02 2004-09-27 Илан Корпорейшн, Плк. Композиции в виде множества частиц с модифицированным высвобождением
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US20050137181A1 (en) * 1999-03-17 2005-06-23 Bonner Ernest L. Method for treatment of reactive arthritis or bursitis
US7691831B2 (en) * 1999-03-17 2010-04-06 Ernest L. Bonner, Jr. Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
US6765000B2 (en) * 1999-03-17 2004-07-20 Bonner Jr Ernest L Treatment for reactive arthritis or bursitis
US7884090B2 (en) * 1999-03-17 2011-02-08 Ernest L. Bonner, Jr. Compositions and methods for the treatment of arthritis
EP1165054A4 (en) 1999-04-06 2005-02-09 Pharmaquest Ltd PHARMACEUTICAL DOSAGE FORM FOR INTERMITTENT DELIVERY OF METHYLPHENIDATE
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
EP1231901A4 (en) * 1999-10-29 2005-03-23 Fmc Corp EDIBLE COATING COMPOSITION
CA2389235C (en) 1999-10-29 2007-07-17 Euro-Celtique, S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
KR100968128B1 (ko) 2000-10-30 2010-07-06 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
BR0115585A (pt) 2000-11-28 2005-12-13 Fmc Corp Composições de revestimento de pronta liberação, endurecìvel, comestìvel, seca e, úmida, forma de dosagem sólida, e, método para revestir uma forma de dosagem sólida farmacêutica ou veterinária, confeito, semente, ração animal, fertilizante, comprimido de pesticida ou alimento
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
WO2002083106A1 (en) * 2001-04-05 2002-10-24 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
CA2449731A1 (en) * 2001-06-07 2002-12-19 Tanabe Seiyaku Co., Ltd. Functional grain-containing preparations quickly disintegrated in the oral cavity
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
AU2003250218B2 (en) 2002-12-20 2006-10-26 F. Hoffmann-La Roche Ag High dose Ibandronate formulation
ES2534827T3 (es) 2003-04-07 2015-04-29 Supernus Pharmaceuticals, Inc. Formulaciones de tetraciclinas en dosis única diaria
GB2414668B (en) * 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
JP5563735B2 (ja) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
US20060121112A1 (en) * 2004-12-08 2006-06-08 Elan Corporation, Plc Topiramate pharmaceutical composition
JP2008535922A (ja) * 2005-04-12 2008-09-04 エラン・ファルマ・インターナショナル・リミテッド 細菌感染を治療するためのセファロスポリンを含む放出制御組成物
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US20080318910A1 (en) * 2005-10-04 2008-12-25 Mistral Pharma, Inc. Controlled-Release Oral Dosage Form
US20070166273A1 (en) * 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
PT103661B (pt) * 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
CA2684985A1 (en) * 2007-03-16 2008-09-25 Elan Pharma International Limited Combination of a narcotic and a non-narcotic analgesic
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
RU2010119041A (ru) 2007-10-12 2011-11-20 Такеда Фармасьютикалз Норт Америка, Инк. (Us) Способы лечения нарушений желудочно-кишечного тракта, независимого от потребления пищи
EP2699236B1 (en) 2011-04-22 2018-06-20 Napo Pharmaceuticals Inc Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (ndga)
WO2012150246A1 (de) 2011-05-05 2012-11-08 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur gezielten freigabe von wirkstoffen
DE102011075354A1 (de) * 2011-05-05 2012-11-08 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur gezielten Freigabe von Wirkstoffen
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
US11103517B2 (en) 2015-04-07 2021-08-31 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for minocycline
CN108414466A (zh) * 2018-03-09 2018-08-17 浙江美华鼎昌医药科技有限公司 一种盐酸米诺环素缓释片体外溶出测定方法
MX2020011599A (es) * 2018-04-30 2021-01-15 Melinta Therapeutics Inc Métodos de tratamiento de infecciones bacterianas con minociclina.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL122039C (cs) * 1960-10-20
US3865935A (en) * 1972-08-10 1975-02-11 Abbott Lab Tableting of erythromycin base
US4250166A (en) * 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
FR2447192A1 (fr) * 1979-01-25 1980-08-22 Adria Lab Inc Forme galenique a liberation prolongee d'indoprofene
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
EP0327295A3 (en) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracycline dosage form
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
ES2064564T3 (es) * 1989-09-21 1995-02-01 American Cyanamid Co Sistema de liberacion pulsatil de dosis unitaria diaria de minociclina.
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation

Also Published As

Publication number Publication date
DE69325402T2 (de) 2000-02-17
HU219580B (hu) 2001-05-28
PL171609B1 (pl) 1997-05-30
KR100270491B1 (ko) 2000-11-01
CN1078889A (zh) 1993-12-01
IL104865A (en) 1997-02-18
LV12399B (en) 2000-06-20
SG47785A1 (en) 1998-04-17
ATE181504T1 (de) 1999-07-15
AU3384293A (en) 1993-09-09
US5348748A (en) 1994-09-20
HK1009930A1 (en) 1999-06-11
NZ245951A (en) 1994-06-27
JPH069407A (ja) 1994-01-18
CA2090561C (en) 2004-10-05
IL104865A0 (en) 1993-06-10
MX9300998A (es) 1993-09-01
GR3031028T3 (en) 1999-12-31
DE69325402D1 (de) 1999-07-29
TW299235B (cs) 1997-03-01
US5262173A (en) 1993-11-16
NO930743L (no) 1993-09-03
FI930906A0 (fi) 1993-03-01
NO930743D0 (no) 1993-03-01
CA2090561A1 (en) 1993-09-03
AU656841B2 (en) 1995-02-16
CZ30093A3 (en) 1994-02-16
FI930906L (fi) 1993-09-03
HUT64851A (en) 1994-03-28
EP0558913B1 (en) 1999-06-23
LV12399A (lv) 1999-12-20
ZA931444B (en) 1993-10-14
CN1039194C (zh) 1998-07-22
KR930019209A (ko) 1993-10-18
HU9300570D0 (en) 1993-05-28
PL297903A1 (en) 1993-11-15
DK0558913T3 (da) 1999-12-13
EP0558913A1 (en) 1993-09-08
ES2134221T3 (es) 1999-10-01
CZ283684B6 (cs) 1998-06-17
FI110163B (fi) 2002-12-13

Similar Documents

Publication Publication Date Title
NO307170B1 (no) Farmasoetisk avgivelsessystem og fremgangsmåte for fremstilling derav
CA2025703A1 (en) Pulsatile once-a-day delivery systems for minocycline
US4784858A (en) Controlled release tablet
CA2140254C (en) Controlled release morphine preparation
EP0698389B1 (en) Controlled release matrix for pharmaceuticals
US5773031A (en) Acetaminophen sustained-release formulation
EP0249347A3 (en) Controlled release dihydrocodeine composition
IL119627A0 (en) Controlled-release pharmaceutical preparations
GR3036798T3 (en) Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules
CA2383212C (en) Controlled release oral dosage suitable for oral administration
EP0425298A3 (en) Sustained-release preparation of basic medical agent hydrochloride
US6129931A (en) Controlled-release, drug-delivery tableted composition including a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone
NZ315632A (en) Process for preparing solid dosage forms of very low-dose drugs comprising admixing 1-3% by weight of carrier particles with a solution of drug in water
EP0439858A1 (en) Veterinary phenytoin composition
CA2187153A1 (en) Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules
CA2161683A1 (en) Veterinary composition containing a proton pump inhibitor
MY114610A (en) Controlled drug delivery system for diltiazem.
MY110769A (en) Controlled release oxycodone compositions.
EP0207514A3 (en) 1,4-dihydropyridine derivatives, process for preparing them, pharmaceutical composition and use
RU97115937A (ru) Применение изосорбид-5-мононитрата

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees